Home Health Care News July 17, 2019
Bailey Bryant

CVS has entered the in-home dialysis market.

The company announced Wednesday it is beginning a clinical trial of its new home hemodialysis system this week. By enabling in-home treatment, CVS could allow patients with end-stage kidney disease to receive more frequent care, with the goal being to improve outcomes.

Typically, patients with kidney disease have to visit dialysis centers three times per week for three to five hours at a time for treatment.

Patients participating in the trial, on the other hand, will get dialysis every other day for around 6 hours per day using the at-home machines, CVS Executive Vice President Alan Lotvin said, according to Reuters.

More dialysis has been shown...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Home, Patient / Consumer, Pharma, Physician, Post-Acute Care, Provider, Retail care
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
FDA launches initiative to advance home healthcare models, devices
Novant Health launches 'hospital at home' with $2.7M donation
FDA initiative puts AR/VR at heart of home health drive
Understanding the Value of the Home as a Healthcare Site

Share This Article